This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
717 |
4. Check minimum number of eventsNone |
717 |
5. Include endpointsNone |
717 |
6. Filter based on genotype QC (FinnGen only) |
643 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Disorders in reading
based on the number of shared cases.
Similar with more cases:
- Specific development disorders of scholastic skills
- Speech and linguistic disorders, excluding more controls
- Speech and linguistic disorders
- Disorders of psychological development
- Any mental disorder
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 643 | 326 | 317 |
| Unadjusted period prevalence (%) | 0.13 | 0.12 | 0.15 |
| Median age at first event (years) | 14.99 | 17.75 | 12.14 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 683
- Matched controls
- 6830
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F81.0
ICD-10 Finland
Specific reading disorder
9236.5
307.7
642
7
F81.1
ICD-10 Finland
Specific spelling disorder
201.7
101.4
103
6
F90.0
ICD-10 Finland
Disturbance of activity and attention
5.0
78.4
218
582
F80.1
ICD-10 Finland
Expressive language disorder
9.3
52.4
66
78
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.6
51.6
230
838
Z2445
NOMESCO Finland
Psychologist
4.5
49.7
142
377
N06BA04
ATC
methylphenidate; oral
4.0
48.7
168
512
XA800
NOMESCO Finland
Neuropsychological investigation
5.3
48.3
109
238
3150A
ICD-9 Finland
Specific delays in development, Specific reading disorder
+∞
47.4
45
*
F81.9
ICD-10 Finland
Developmental disorder of scholastic skills, unspecified
11.2
45.1
49
47
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
4.6
43.6
115
285
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
13.2
41.2
40
32
F81.3
ICD-10 Finland
Mixed disorder of scholastic skills
9.6
39.0
47
52
F80.2
ICD-10 Finland
Receptive language disorder
8.7
37.6
49
60
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.1
36.7
197
784
ZY010
NOMESCO Finland
Hospital outpatient
3.7
32.8
121
380
N06AX16
ATC
venlafaxine; oral
3.2
31.6
153
569
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
4.4
31.4
85
213
N05AH04
ATC
quetiapine; oral
2.7
29.0
210
966
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
6.7
28.6
47
75
IBZ06
NOMESCO Finland
Evaluation concerning developmental neuropsychiatry
6.8
26.7
43
67
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.1
26.2
126
463
Z2446
NOMESCO Finland
Social worker
3.1
25.9
127
472
N06AX21
ATC
duloxetine; oral
3.3
25.1
106
360
F98.8
ICD-10 Finland
Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
9.7
23.7
28
30
331
Kela drug reimbursment
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
4.3
23.3
63
157
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
3.3
23.2
95
316
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
4.6
22.9
56
129
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
3.3
22.5
95
322
N06AB03
ATC
fluoxetine; oral
3.0
22.1
110
410
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.2
21.9
96
332
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.3
21.6
87
286
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.7
21.3
72
211
Z2221
NOMESCO Finland
Medical doctor
2.3
21.0
220
1175
IGY99
NOMESCO Finland
Other psychiatric treatment contact
3.5
20.6
78
246
N06AX11
ATC
mirtazapine; oral
2.2
20.1
228
1253
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
3.5
20.0
73
225
3152A
ICD-9 Finland
Specific delays in development, Other specific learning difficulties
+∞
19.9
19
*
F80.9
ICD-10 Finland
Developmental disorder of speech and language, unspecified
7.1
19.7
30
44
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.3
19.4
77
250
N06AB04
ATC
citalopram; systemic
2.7
19.4
122
514
Z01.8
ICD-10 Finland
Other specified special examinations
2.4
19.4
167
816
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
3.6
19.1
67
201
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
4.6
19.0
47
109
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.3
18.9
75
244
3153A
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[KIELENKEHITYKSEN ERITYISVAIKEUS]
28.8
18.8
25
9
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.2
18.5
77
258
Z3231
NOMESCO Finland
Registered nurse
2.1
18.4
236
1354
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
3.4
18.4
71
227
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.3
18.1
71
229
F82
ICD-10 Finland
Specific developmental disorder of motor function
4.9
18.0
40
85
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.5
17.7
126
562
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.9
17.6
90
339
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.6
17.5
60
177
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
4.2
17.5
48
121
N06BA12
ATC
lisdexamfetamine; oral
4.1
17.5
50
130
IGY02
NOMESCO Finland
Psychiatric monitoring contact
2.9
17.3
91
348
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
3.8
16.8
53
148
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
3.2
16.2
67
223
N06AB10
ATC
escitalopram; oral
2.1
16.2
199
1115
L12
ICPC
Hand/finger symptom/complaint
2.2
15.9
175
938
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
14.8
210
1233
N06AB06
ATC
sertraline; oral
2.3
14.8
130
635
J45.9
ICD-10 Finland
Asthma, unspecified
2.2
14.6
138
693
ZXA05
NOMESCO Finland
Left side
2.4
14.6
108
488
Z3226
NOMESCO Finland
Physiotherapist
2.2
14.3
148
771
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
3.9
14.3
43
116
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.9
14.2
389
2828
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
14.1
231
1422
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
3.0
14.0
64
226
N05AX08
ATC
risperidone; systemic
2.8
13.9
74
284
Z13.4
ICD-10 Finland
Special screening examination for certain developmental disorders in childhood
54.5
13.9
16
*
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
3.0
13.8
63
222
N06BA09
ATC
atomoxetine; oral
5.4
13.5
27
52
N03AX09
ATC
lamotrigine; oral
2.9
13.5
69
259
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.5
13.4
95
420
N06AG02
ATC
moclobemide; oral
5.0
13.4
29
60
N06AX12
ATC
bupropion; oral
2.4
13.4
102
466
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
2.6
13.4
80
326
ZXE20
NOMESCO Finland
More than three and less than five hours
2.6
13.4
85
357
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
13.1
229
1433
L17
ICPC
Foot/toe symptom/complaint
1.9
13.0
218
1345
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.3
12.6
103
485
ZXE00
NOMESCO Finland
One hour or less
1.8
12.6
268
1781
SPAT1283
SPAT
Restricted health certificate
1.8
12.4
243
1572
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.4
12.4
92
415
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
3.6
12.4
41
118
K02.1
ICD-10 Finland
Caries of dentine
1.9
12.4
497
3990
N05AH03
ATC
olanzapine; systemic
2.5
12.4
80
339
A29
ICPC
General symptom/complaint other
2.4
12.3
96
443
F34.1
ICD-10 Finland
Dysthymia
3.4
12.3
45
139
S18
ICPC
Laceration/cut
1.8
12.2
273
1839
SFA20
NOMESCO Finland
Two-surface restoration
1.8
12.0
428
3298
D01
ICPC
Abdominal pain/cramps general
2.0
11.7
143
788
A05
ICPC
Feeling ill
2.1
11.7
122
635
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
11.7
350
2557
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
11.7
115
585
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.0
11.6
161
928
R03AC02
ATC
salbutamol; inhalant
1.8
11.5
395
2992
F43.1
ICD-10 Finland
Post-traumatic stress disorder
3.0
11.5
52
182
N05BA04
ATC
oxazepam; oral
2.0
11.5
156
892
R4110
NOMESCO Finland
Physiotherapy
1.9
11.3
170
1006
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
11.3
181
1094
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.2
11.3
100
487
N05AX12
ATC
aripiprazole; systemic
2.6
11.3
67
272
P24
ICPC
Specific learning problem
3.6
11.3
38
111
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
5.4
11.1
22
42
E66.8
ICD-10 Finland
Other obesity
3.1
11.0
48
165
F90.9
ICD-10 Finland
Hyperkinetic disorder, unspecified
4.0
10.9
31
80
R02
ICPC
Shortness of breath/dyspnoea
2.3
10.9
86
399
A97
ICPC
No disease
1.9
10.9
187
1155
WX110
NOMESCO Finland
Infiltration anesthesia
1.9
10.8
545
4584
SFA10
NOMESCO Finland
One-surface restoration
1.7
10.7
440
3478
ZYC01
NOMESCO Finland
Remote contact by phone
2.5
10.6
68
286
IBB02
NOMESCO Finland
Psychiatric evaluation of working capacity and rehabilitation
5.4
10.6
21
40
P06
ICPC
Sleep disturbance
2.1
10.6
118
627
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.0
10.6
128
701
K04.08
ICD-10 Finland
Other specified pulpit
2.3
10.6
88
417
XW000
NOMESCO Finland
Bone marrow biopsy
4.6
10.6
25
56
SAA01
NOMESCO Finland
Simple examination of mouth
2.0
10.5
565
4824
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.2
10.5
28
69
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.9
10.5
161
958
SPAT1307
SPAT
Psychosocial counselling and guidance
2.1
10.4
111
580
Z02.7
ICD-10 Finland
Issue of medical certificate
2.5
10.4
65
271
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
3.2
10.3
41
133
N06AX05
ATC
trazodone; oral
4.5
10.3
25
57
F80.8
ICD-10 Finland
Other developmental disorders of speech and language
9.0
10.3
21
24
N03AG01
ATC
valproic acid; systemic, rectal
2.7
10.3
58
229
R03AC03
ATC
terbutaline; inhalant
2.2
10.3
90
435
F93.89
ICD-10 Finland
Other childhood emotional disorders
3.5
10.3
36
108
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.9
10.2
138
785
Z3229
NOMESCO Finland
Other healthcare associate professional
2.4
10.2
70
305
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.7
10.2
335
2479
R5599
NOMESCO Finland
Other rehabilitation service
3.6
10.2
33
94
N06AX26
ATC
vortioxetine; oral
2.2
10.1
89
431
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
2.8
10.1
51
190
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
4.1
10.1
28
71
G47.3
ICD-10 Finland
Sleep apnoea
2.1
10.0
108
567
R03BA02
ATC
budesonide; inhalant
2.0
9.9
131
741
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
9.8
277
1961
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.3
9.8
77
356
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
3.7
9.8
31
87
IGV01
NOMESCO Finland
Psychiatric network contact
3.2
9.8
38
122
D06
ICPC
Abdominal pain localized other
2.3
9.7
80
377
IEP03
NOMESCO Finland
Focused parental counselling
4.3
9.7
25
60
N06AX22
ATC
agomelatine; oral
3.5
9.7
34
102
TAB00
NOMESCO Finland
Lumbar puncture
2.9
9.6
45
161
N39.4
ICD-10 Finland
Other specified urinary incontinence
4.1
9.6
26
65
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
3.6
9.6
32
93
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
4.2
9.5
25
61
P76
ICPC
Depressive disorder
2.2
9.5
87
429
M79.6
ICD-10 Finland
Pain in limb
1.7
9.4
261
1835
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.9
9.4
127
723
KMAK, ,
NOMESCO Finland
1.6
9.2
330
2473
IAZ98
NOMESCO Finland
Other internal psychiatric consultation
5.1
9.1
19
38
WZC00
NOMESCO Finland
Treatment plan or consultation
1.6
9.0
288
2094
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
8.9
121
688
F84.8
ICD-10 Finland
Other pervasive developmental disorders
8.8
8.8
18
21
EB1VA, ,
NOMESCO Finland
1.9
8.8
118
668
F84.5
ICD-10 Finland
Asperger syndrome
3.8
8.8
27
74
A01
ICPC
Pain general/multiple sites
2.3
8.8
66
299
SFA30
NOMESCO Finland
Three-surface restoration
1.7
8.8
220
1500
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.4
8.7
60
261
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.8
8.7
45
170
N05AA02
ATC
levomepromazine; systemic
3.5
8.7
30
89
-, ,
ICD-10 Finland
7.8
8.7
19
25
N05CF01
ATC
zopiclone; oral
1.9
8.6
121
697
UJF32
NOMESCO Finland
Coloscopy
2.1
8.5
91
475
RS221, ,
NOMESCO Finland
3.8
8.5
26
71
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
3.8
8.5
26
71
F81.2
ICD-10 Finland
Specific disorder of arithmetical skills
27.9
8.5
11
*
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.8
8.5
145
886
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.2
8.5
75
364
IGP01
NOMESCO Finland
Psychiatric family contact
2.8
8.5
43
161
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.5
8.4
52
215
R51.80
ICD-10 Finland
Headache
1.8
8.4
155
968
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.1
8.4
88
456
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
8.3
97
523
RD210, ,
NOMESCO Finland
2.8
8.3
42
157
SPAT1249
SPAT
Treatment-related counselling outside office
1.6
8.3
265
1917
H01
ICPC
Ear pain/earache
1.8
8.3
149
924
R06.0
ICD-10 Finland
Dyspnoea
1.8
8.2
130
777
N02AX02
ATC
tramadol; systemic, rectal
1.7
8.2
175
1141
R74
ICPC
Upper respiratory infection acute
1.6
8.1
352
2734
N05BA01
ATC
diazepam; systemic, rectal
2.2
8.1
67
316
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.1
8.1
33
109
R4190
NOMESCO Finland
Nutritional therapy
2.3
8.1
64
297
SPAT1310
SPAT
Counselling related to known health issue
1.6
8.0
224
1564
A02BC02
ATC
pantoprazole; systemic
1.6
8.0
306
2305
N02BE01
ATC
paracetamol; systemic, rectal
1.7
8.0
517
4418
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.6
8.0
47
190
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.9
7.9
38
138
P03
ICPC
Feeling depressed
1.8
7.9
137
839
T83
ICPC
Overweight
3.9
7.9
23
61
SPAT1139
SPAT
Nutrition survey
4.1
7.9
21
52
IEP02
NOMESCO Finland
Child-centred family therapy
3.7
7.8
24
66
ZXA10
NOMESCO Finland
Bilateral
1.9
7.8
104
587
SFA40
NOMESCO Finland
Restoration involving the entire crown of the tooth
2.0
7.8
87
462
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
2.9
7.8
37
134
IEP99
NOMESCO Finland
Other psychiatric family intervention
3.6
7.8
25
71
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
3.3
7.7
29
91
M54.5
ICD-10 Finland
Low back pain
1.6
7.7
225
1586
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
4.6
7.7
18
40
A03
ICPC
Fever
1.6
7.7
212
1474
N01
ICPC
Headache
1.7
7.6
178
1184
H02AB06
ATC
prednisolone; systemic
1.6
7.6
230
1634
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
3.6
7.6
25
72
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
3.1
7.6
32
108
C07AA05
ATC
propranolol; systemic
1.7
7.6
150
954
P29
ICPC
Psychological sympt/compl other
1.9
7.6
113
661
ZX120
NOMESCO Finland
Intravenous
2.4
7.5
54
240
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.7
7.5
164
1072
ZXD05
NOMESCO Finland
Urgent procedure
1.7
7.5
179
1198
SAA02
NOMESCO Finland
Basic examination of mouth
1.8
7.5
579
5138
H52.0
ICD-10 Finland
Hypermetropia
3.1
7.4
31
104
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
7.4
135
838
F32
ICD-10 Finland
Depressive episode
2.3
7.4
57
261
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
2.6
7.4
41
161
RS220, ,
NOMESCO Finland
3.7
7.4
23
64
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
2.2
7.3
61
289
F80.0
ICD-10 Finland
Specific speech articulation disorder
4.4
7.3
18
42
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.6
7.2
230
1650
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
7.1
177
1195
WX002
NOMESCO Finland
Sedation and analgesia
2.0
7.1
85
462
EBA00
NOMESCO Finland
Extraction of tooth
1.5
7.1
317
2455
E66.01
ICD-10 Finland
Obesity due to excess calories
2.0
7.1
79
419
IEV99
NOMESCO Finland
Other psychiatric network intervention
3.4
7.0
25
76
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
6.4
7.0
17
27
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.8
7.0
34
125
J45.1
ICD-10 Finland
Nonallergic asthma
2.2
6.9
61
296
Z71.8
ICD-10 Finland
Other specified counselling
1.5
6.9
267
2001
S29
ICPC
Skin symptom/complaint other
1.7
6.9
139
888
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.2
6.9
60
290
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.7
6.8
132
832
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.9
6.8
20
53
U07
ICPC
Urine symptom/complaint other
2.4
6.8
47
205
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.5
6.8
43
180
A06AC01
ATC
ispaghula (psylla seeds); oral
1.9
6.8
93
528
L02
ICPC
Back symptom/complaint
1.9
6.8
92
521
127
Kela drug reimbursment
Transplant complication
3.7
6.8
21
58
N06AA12
ATC
doxepin; systemic
3.7
6.8
21
58
120
Kela drug reimbursment
Hypogammaglobulinaemia
40.5
6.8
8
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.3
6.8
53
245
N06AX18
ATC
reboxetine; oral
16.9
6.8
10
6
XCK00
NOMESCO Finland
Perimetry
3.3
6.8
25
78
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
6.7
88
493
A04
ICPC
Weakness/tiredness general
1.7
6.6
135
863
R96
ICPC
Asthma
2.2
6.6
56
267
G56.0
ICD-10 Finland
Carpal tunnel syndrome
2.1
6.6
61
301
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.5
6.6
40
165
WX290
NOMESCO Finland
Other blockage of nerve
1.5
6.5
407
3362
IGY02, ,
SPAT
3.2
6.5
25
80
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
6.3
6.5
16
26
WX290, ,
SPAT
2.5
6.5
41
172
SGA01
NOMESCO Finland
Emergency treatment
1.7
6.5
122
763
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
6.5
111
676
AA1AD
NOMESCO Finland
CT of head and brain
1.8
6.5
98
575
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.6
6.5
37
148
C07AB07
ATC
bisoprolol; oral
1.7
6.4
123
774
N05AB03
ATC
perphenazine; systemic, rectal
3.2
6.4
25
81
N17
ICPC
Vertigo/dizziness
2.0
6.3
73
392
G44.2
ICD-10 Finland
Tension-type headache
1.8
6.3
94
549
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
3.9
6.3
18
47
N03AE01
ATC
clonazepam; systemic
2.8
6.3
30
109
F94.8
ICD-10 Finland
Other childhood disorders of social functioning
18.2
6.3
9
5
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
+∞
6.3
6
*
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
6.2
118
739
J45.8
ICD-10 Finland
Mixed asthma
3.2
6.2
24
77
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.6
6.2
34
133
F40.1
ICD-10 Finland
Social phobias
2.2
6.2
50
234
N03AX16
ATC
[U] pregabalin
1.9
6.2
84
476
ZXD20
NOMESCO Finland
Day surgery
1.9
6.2
74
403
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
6.1
113
703
F45.8
ICD-10 Finland
Other somatoform disorders
2.0
6.1
65
339
R11
ICD-10 Finland
Nausea and vomiting
1.9
6.1
78
434
K59.09
ICD-10 Finland
Constipation, unspecified
2.4
6.1
39
165
S02
ICPC
Pruritus
2.5
6.1
37
153
E66.9
ICD-10 Finland
Obesity, unspecified
2.6
6.0
35
141
Z06
ICPC
Unemployment problem
3.9
6.0
17
44
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
214
1056
2.49
25.06
2.6
1.8
1.54
1.38
%
3.08
202
974
347
2221
2.14
20.95
8.3
6.2
10.21
10.68
umol/l
0.36
334
2094
240
1329
2.24
20.94
3.9
3.1
1.02
1.02
kg/l
0.07
155
838
300
1817
2.16
20.88
8.9
6.1
37.94
38.29
g/l
0.53
284
1728
315
1979
2.10
19.58
18.7
8.6
1.22
1.22
mmol/l
0.07
300
1868
336
2181
2.06
18.93
17.1
8.4
1.21
1.21
mmol/l
0.49
308
1941
303
1894
2.08
18.91
5.2
3.7
35.52
30.33
u/l
0.59
293
1811
202
1090
2.21
18.40
2.6
2.4
182.43
286.02
u/l
0.80
188
1055
239
1384
2.12
18.13
3.1
2.9
2.36
2.37
mmol/l
0.21
224
1296
477
3575
2.11
17.50
8.6
6.8
84.42
86.18
u/l
0.31
464
3394
256
1544
2.05
17.24
4.5
3.9
8.90
9.06
mmol/l
0.17
250
1411
87
332
2.86
16.59
5.2
4.7
—
—
—
0
0
164
854
2.21
16.06
4.7
2.9
0.82
0.64
e6/l
0.31
87
412
551
4428
2.26
16.01
5.0
4.1
14.35
14.45
pmol/l
0.52
538
4128
442
3363
1.89
13.77
16.6
10.4
3.80
3.81
e9/l
0.03
389
2911
614
5276
2.62
13.56
22.2
10.9
139.77
139.57
mmol/l
1.86
606
5148
226
1399
1.92
13.46
5.3
3.4
0.20
0.18
e6/l
0.05
162
997
551
4536
2.11
13.38
4.4
3.1
5.64
5.55
mmol/l
1.00
536
4248
613
5288
2.55
12.98
22.2
10.9
3.89
3.91
mmol/l
0.81
603
5134
57
199
3.03
12.70
2.5
3.2
65.46
66.66
g/l
0.44
50
192
245
1581
1.86
12.69
5.5
3.6
15.58
56.21
e6/l
1.44
183
1171
89
392
2.46
12.67
1.8
1.6
0.36
0.25
mg/l
0.45
33
179
333
2378
1.78
12.19
3.6
3.0
64.59
68.31
nmol/l
1.95
321
2261
474
3770
1.84
11.90
5.2
4.1
8.46
7.16
mm/h
2.21
455
3558
176
1046
1.92
11.60
3.6
3.1
7.38
7.92
e6/l
0.13
157
943
431
3360
1.77
11.26
5.5
3.9
315.00
166.55
e6/l
—
6
38
252
1688
1.78
11.25
2.0
1.7
97.93
96.19
pmol/l
0.28
152
936
74
325
2.43
10.57
18.8
12.4
0.73
0.23
mmol/l
0.43
58
276
589
5113
2.10
10.33
6.0
4.8
1.78
1.78
mu/l
0.07
575
4875
47
166
2.97
10.27
1.9
1.9
—
—
—
0
0
144
833
1.92
10.17
5.2
3.1
3.08
2.86
e6/l
0.04
68
397
40
130
3.21
10.06
4.5
3.3
25.64
22.58
mu/l
0.19
40
125
373
2853
1.68
9.88
12.5
5.5
6.22
6.27
mmol/l
0.15
346
2596
371
2840
1.67
9.74
4.5
3.3
0.00
2.61
estimate
0.50
43
577
87
428
2.18
9.53
1.6
1.6
1101.04
1084.90
nmol/l
0.07
71
341
120
671
1.96
9.31
6.5
4.2
29.50
29.83
s
0.30
120
664
92
475
2.08
8.89
2.7
1.7
—
—
—
0
0
365
2823
1.63
8.88
4.4
3.3
0.00
0.00
estimate
0.50
45
598
369
2863
1.63
8.85
4.6
3.3
0.00
0.00
estimate
-0.00
46
566
645
5885
2.73
8.85
14.9
9.2
33.14
27.88
u/l
1.09
634
5764
95
499
2.05
8.77
24.0
9.2
104.65
105.09
mmol/l
0.56
95
499
90
464
2.08
8.73
2.6
1.8
—
—
—
0
0
515
4368
1.73
8.54
5.4
4.0
36.42
36.54
mmol/mol
0.09
501
4199
126
736
1.87
8.53
14.1
7.0
0.81
0.82
mmol/l
0.23
119
706
48
191
2.63
8.42
1.8
1.9
7.97
6.87
ug/l
0.14
42
169
161
1018
1.76
8.39
1.7
1.4
20.13
19.07
nmol/l
0.46
149
912
109
611
1.93
8.36
2.1
2.1
2.39
2.40
mmol/l
0.31
91
535
172
1110
1.73
8.34
4.4
2.7
1.05
1.03
mg/l
0.03
120
772
204
1381
1.68
8.29
2.7
2.9
2.52
2.46
mg/l
0.14
182
1224
202
1375
1.67
8.00
3.2
2.8
54.27
60.02
u/l
0.66
188
1296
36
128
2.91
7.81
2.8
3.2
2.79
6.43
index
0.67
19
79
94
518
1.94
7.56
2.6
2.5
27.40
131.91
u/l
0.56
80
425
41
160
2.66
7.49
13.0
8.3
266.57
413.71
iu/ml
—
7
17
629
5764
2.15
7.01
18.6
11.1
20.85
21.18
mg/l
0.10
538
4418
183
1264
1.61
6.67
3.5
2.4
—
—
—
0
0
392
3206
1.52
6.64
4.7
3.5
76.19
71.81
ug/l
0.31
376
3061
41
171
2.49
6.57
4.7
2.6
2.71
16.61
e6/l
1.34
35
116
58
282
2.15
6.55
2.3
2.5
85.06
84.99
ml/min/173m2
0.00
17
107
105
628
1.79
6.52
2.6
1.9
—
—
—
0
0
41
173
2.46
6.42
4.7
2.6
196.03
189.11
e6/l
0.02
35
124
303
2362
1.51
6.36
3.8
2.9
—
—
estimate
—
0
0
47
212
2.31
6.35
27.0
6.2
0.61
0.57
%
0.25
47
212
533
4688
1.62
6.34
12.0
8.6
104.53
102.78
ml/min/173m2
1.18
466
4012
15
24
6.36
6.19
8.2
6.3
—
—
—
0
0
478
4111
1.54
6.16
5.3
3.5
40.37
33.06
u/l
1.52
466
3984
56
276
2.12
6.12
9.9
5.5
3.09
3.10
g/l
0.02
56
269
60
304
2.07
6.10
2.2
1.7
266.87
173.91
u/ml
1.85
39
158
56
279
2.10
5.95
2.9
1.8
—
—
—
0
0
58
294
2.06
5.89
2.0
1.6
—
—
—
0
0
99
600
1.76
5.86
9.1
4.5
7.48
6.78
umol/l
0.14
85
506
634
5887
2.07
5.85
19.9
11.1
69.07
69.08
umol/l
0.00
627
5810
139
925
1.63
5.82
5.7
3.0
324.23
320.37
umol/l
0.18
129
868
44
202
2.26
5.73
1.3
1.3
—
—
—
0
0
132
874
1.63
5.63
4.4
4.7
11.17
10.16
mg/mmol
0.09
100
624
118
762
1.66
5.54
18.6
9.1
1.15
1.20
mmol/l
1.01
113
718
552
4947
1.60
5.53
4.7
3.6
2.79
2.80
mmol/l
0.01
540
4753
88
525
1.78
5.50
1.6
1.3
205.66
435.78
u/ml
0.73
81
493
247
1899
1.47
5.31
2.2
1.5
1.86
2.00
g/l
0.92
144
1156
106
677
1.67
5.18
23.8
7.5
0.61
1.35
mmol/l
1.04
92
577
13
23
5.74
5.08
5.2
4.5
1603.77
1823.83
mg
0.12
13
23
514
4563
1.51
5.07
3.8
3.1
1.28
1.21
mmol/l
1.32
498
4366
270
2134
1.44
4.93
1.7
1.6
1.40
2.26
u/ml
0.57
57
536
545
4912
1.54
4.88
4.3
3.5
1.31
1.39
mmol/l
5.78
532
4721
547
4945
1.53
4.72
4.4
3.5
4.51
4.59
mmol/l
1.46
533
4774
171
1249
1.49
4.66
2.6
2.4
50.23
28.45
ng/l
0.39
67
523
45
228
2.04
4.61
3.0
1.8
96.20
120.44
au/ml
0.75
20
75
95
608
1.65
4.60
5.2
4.8
318.87
704.49
ng/l
0.78
75
474
135
941
1.54
4.58
1.3
1.3
17.90
20.53
iu/ml
0.21
35
225
9
11
8.27
4.57
2.2
1.4
1.39
0.43
mg/l
—
9
6
9
11
8.27
4.57
2.2
1.4
0.56
0.72
mg/l
—
9
6
23
87
2.70
4.53
10.7
3.2
—
—
—
0
0
30
130
2.37
4.49
1.6
1.7
18.64
30.98
ng/l
0.69
30
130
21
76
2.82
4.48
1.0
1.1
—
—
—
0
0
103
678
1.61
4.46
1.5
1.5
449.76
30164369.69
pmol/l
0.76
91
610
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
21
78
2.75
4.29
11.8
11.8
0.40
0.37
iu/ml
0.18
11
44
80
500
1.68
4.25
2.1
1.9
7.09
12.46
iu/l
3.22
49
377
245
1952
1.40
4.11
2.1
1.8
1.59
1.36
mmol/l
2.55
237
1770
63
372
1.76
4.10
1.6
1.4
—
—
—
0
0
41
214
1.97
3.91
31.3
14.3
0.70
0.64
%
0.47
41
214
37
186
2.05
3.91
6.1
4.8
26.35
26.90
nmol/l
0.10
37
180
33
159
2.13
3.89
2.5
2.0
1.02
1.02
ratio
0.25
27
139
87
569
1.61
3.87
28.3
7.5
23.37
23.89
mmol/l
0.99
87
569
42
223
1.94
3.82
30.6
13.8
1.55
1.28
%
0.59
42
223
20
78
2.61
3.75
1.0
1.0
—
—
—
0
0
157
1175
1.44
3.70
3.0
3.5
108.20
104.41
ug/g
0.07
135
956
80
522
1.60
3.60
11.5
6.6
5.11
5.09
kpa
0.11
75
505
72
459
1.64
3.56
2.3
2.0
5.00
6.65
u/l
1.78
50
340
25
112
2.28
3.52
2.1
1.4
—
—
—
0
0
17
63
2.74
3.51
1.5
1.8
7356.40
23485.38
e6/l
—
10
50
13
36
3.66
3.51
1.3
1.1
—
—
—
0
0
185
1439
1.39
3.49
4.5
3.4
0.00
0.01
estimate
1.08
43
569
105
735
1.51
3.47
3.7
3.0
505.05
811.64
ng/l
0.40
64
369
44
247
1.84
3.41
28.7
6.7
131.91
135.69
g/l
0.47
44
242
11
27
4.12
3.40
2.5
2.7
9.01
17.44
umol/l
1.91
11
27
19
77
2.51
3.32
6.3
2.6
0.74
0.67
e9/l
0.24
19
77
11
28
3.97
3.30
1.9
1.3
—
—
—
0
0
24
109
2.25
3.29
1.7
1.3
—
—
—
0
0
24
109
2.25
3.29
1.7
1.3
—
—
—
0
0
40
221
1.86
3.26
32.1
13.9
92.72
94.54
%
0.69
40
221
75
494
1.58
3.26
1.5
1.7
250.05
299.15
mu/l
1.84
67
441
22
97
2.31
3.22
11.2
3.0
624.82
503.25
e6/l
0.41
17
69
41
230
1.83
3.19
1.5
1.9
3.14
4.66
iu/ml
—
5
46
19
79
2.45
3.16
1.0
1.1
—
—
—
0
0
10
25
4.04
3.09
1.6
1.6
—
—
—
0
0
36
196
1.88
3.08
1.5
1.7
1.20
1.19
g/l
0.06
36
181
15
56
2.72
3.07
2.6
1.6
—
—
—
0
0
22
100
2.24
3.02
11.4
3.0
201.65
209.37
e6/l
0.08
17
73
9
21
4.33
3.00
7.2
7.3
—
—
—
0
0
18
76
2.41
2.91
1.1
1.1
31.77
40.98
mg/l
0.57
13
62
35
193
1.86
2.90
1.5
1.7
0.23
0.23
g/l
0.13
35
181
15
58
2.62
2.89
1.4
1.2
—
—
—
0
0
10
27
3.74
2.89
1.5
1.4
—
—
—
0
0
288
2451
1.30
2.88
2.2
1.9
—
—
—
0
0
8
18
4.48
2.80
6.5
8.9
—
—
—
0
0
73
498
1.52
2.74
12.2
6.6
1.25
0.93
mmol/l
0.39
50
374
31
168
1.89
2.72
1.2
1.2
—
—
—
0
0
15
60
2.53
2.71
1.4
1.2
—
—
—
0
0
15
60
2.53
2.71
1.2
1.2
0.47
0.67
ratio
—
5
32
15
60
2.53
2.71
1.4
1.2
—
—
—
0
0
8
19
4.25
2.68
3.3
4.5
—
19900.00
—
0
5
8
19
4.25
2.68
3.1
3.9
—
—
—
0
0
15
61
2.49
2.63
1.4
1.2
—
—
—
0
0
31
170
1.86
2.63
1.2
1.2
—
—
—
0
0
17
74
2.33
2.59
5.5
5.6
1.39
1.39
mmol/l
0.01
17
74
12
44
2.76
2.55
4.1
3.7
1.00
0.77
index
0.31
12
44
34
194
1.79
2.55
1.9
1.7
—
—
—
0
0
160
1277
1.33
2.49
3.8
2.3
—
—
—
0
0
24
123
1.99
2.48
1.4
1.3
—
—
—
0
0
15
63
2.41
2.47
5.9
5.3
3.72
3.84
mmol/l
0.48
15
63
15
63
2.41
2.47
1.4
1.2
—
—
—
0
0
14
57
2.49
2.46
8.8
7.2
8.47
9.54
mg/l
0.39
14
52
249
2113
1.28
2.45
3.8
3.0
0.00
0.02
estimate
1.13
36
512
114
869
1.37
2.39
1.3
1.2
2.41
6.08
u/ml
1.44
38
348
23
118
1.98
2.38
1.1
1.4
402.13
336.21
ug/g
—
8
65
7
17
4.15
2.36
1.1
1.1
—
—
—
0
0
7
17
4.15
2.36
1.1
1.1
—
—
—
0
0
23
119
1.97
2.33
1.3
1.3
—
1.07
—
0
8
15
66
2.30
2.26
1.4
1.2
—
—
—
0
0
17
80
2.15
2.20
4.2
3.4
—
—
—
0
0
246
2111
1.26
2.16
3.0
2.5
—
—
—
0
0
667
6512
2.04
2.16
29.7
16.6
4.70
4.68
e12/l
0.50
657
6364
40
253
1.62
2.12
4.3
3.2
8.25
6.80
umol/l
0.26
29
198
5
10
5.03
2.07
1.2
1.0
—
—
—
0
0
15
69
2.20
2.06
1.0
1.1
—
—
—
0
0
666
6506
1.95
2.03
29.8
16.7
269.85
260.43
e9/l
3.51
658
6368
26
148
1.79
2.01
4.1
9.0
24.95
23.74
mmol/l
1.01
26
142
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
38
2.66
2.01
1.3
1.1
—
—
—
0
0
230
1977
1.25
1.96
3.0
2.3
—
—
—
0
0
14
64
2.21
1.95
1.6
1.7
—
—
—
0
0
5
11
4.57
1.94
1.2
1.0
—
—
—
0
0
15
71
2.14
1.93
2.7
2.2
—
—
—
0
0
86
651
1.37
1.90
3.0
2.5
2051.13
6595.99
u/l
2.40
27
262
51
723
0.68
1.89
1.2
1.5
3.69
3.38
mmol/l
0.62
27
474
80
599
1.38
1.89
1.1
1.1
—
—
—
0
0
34
216
1.60
1.80
2.2
2.0
209.41
227.86
pmol/l
0.26
34
208
9
36
2.52
1.74
5.2
5.5
—
—
—
0
0
9
36
2.52
1.74
5.2
5.5
—
—
—
0
0
32
202
1.61
1.74
1.5
1.3
—
—
—
0
0
5
13
3.87
1.72
1.2
1.7
—
—
—
0
0
5
13
3.87
1.72
6.4
11.5
—
—
—
0
0
15
75
2.02
1.70
1.9
1.6
—
—
—
0
0
27
164
1.67
1.70
1.3
1.3
—
61.84
—
0
8
26
157
1.68
1.68
1.3
1.3
—
10.35
—
0
22
11
49
2.27
1.64
2.2
2.2
140.09
126.24
%
0.27
11
49
26
159
1.66
1.61
1.3
1.3
—
2.62
—
0
11
6
20
3.02
1.58
3.2
4.3
154.17
200.10
ug/l
—
6
20
7
26
2.71
1.58
2.6
1.6
—
—
—
0
0
17
92
1.87
1.57
3.5
1.8
—
—
—
0
0
8
33
2.44
1.54
1.4
1.4
61.63
74.12
umol/l
—
8
33
5
15
3.35
1.52
1.2
1.3
—
—
—
0
0
25
154
1.65
1.52
3.3
1.8
—
—
—
0
0
63
472
1.37
1.52
1.4
1.3
—
—
—
0
0
48
344
1.43
1.49
1.9
1.8
—
—
—
0
0
17
94
1.83
1.48
3.8
1.6
—
—
—
0
0
5
16
3.14
1.44
1.2
1.1
—
—
—
0
0
5
16
3.14
1.44
1.2
1.2
—
—
—
0
0
24
149
1.63
1.43
3.2
1.7
—
—
—
0
0
73
923
0.77
1.36
1.2
1.6
4.10
3.51
ratio
2.01
47
669
9
42
2.16
1.34
2.3
1.2
—
—
—
0
0
15
83
1.83
1.32
1.5
2.0
—
—
—
0
0
8
34
2.37
1.29
1.6
1.0
—
—
—
0
0
5
18
2.79
1.28
30.2
20.2
0.26
0.44
umol/l
—
5
18
10
48
2.10
1.28
1.8
1.9
—
—
—
0
0
33
229
1.46
1.24
1.6
1.7
9.77
9.74
u/ml
—
6
69
31
214
1.47
1.20
2.4
2.0
39.42
41.31
u/l
0.25
26
204
23
149
1.56
1.18
2.2
5.3
24.11
25.17
mmol/l
1.32
23
143
23
149
1.56
1.18
1.3
1.3
—
—
—
0
0
40
291
1.40
1.18
1.7
1.7
3.02
3.52
mg/l
0.31
34
194
11
58
1.91
1.12
1.3
1.2
—
—
—
0
0
7
30
2.35
1.12
6.7
4.8
17.10
19.03
ug/l
—
7
30
8
40
2.01
1.12
1.1
1.5
70.87
87.88
%
—
8
40
24
349
0.68
1.09
1.0
1.1
1.40
1.47
g/l
0.79
24
349
11
59
1.88
1.08
1.5
1.5
—
—
—
0
0
40
298
1.36
1.05
1.3
1.5
—
—
—
0
0
27
381
0.70
1.05
1.8
1.8
—
—
—
0
0
25
353
0.70
0.98
1.0
1.1
0.95
0.88
g/l
0.64
25
353
14
84
1.68
0.98
2.1
2.2
—
—
—
0
0
7
36
1.95
0.97
2.4
1.9
10.47
10.81
mmol/l
—
7
36
12
70
1.73
0.93
3.5
2.0
136.17
125.74
ng/l
0.17
12
65
9
52
1.74
0.92
1.0
1.1
276.22
283.50
mg/l
—
9
46
57
458
1.27
0.91
2.6
2.7
31.52
22.20
%
0.79
12
105
41
316
1.32
0.89
2.3
1.9
30.10
36.49
nmol/l
1.36
41
310
8
42
1.92
0.88
1.4
1.2
98.75
114.10
pmol/l
—
8
42
8
43
1.87
0.87
1.4
1.1
—
—
—
0
0
25
178
1.42
0.87
1.6
1.7
—
—
—
0
0
8
46
1.75
0.82
2.6
1.6
—
—
—
0
0
73
611
1.22
0.82
2.6
2.7
1.08
1.17
ug/l
0.26
67
561
70
585
1.22
0.80
1.3
1.3
78.27
123.71
u/ml
0.57
18
211
23
167
1.39
0.74
1.2
1.2
—
—
—
0
0
9
55
1.64
0.73
1.3
1.2
14.97
54.31
u/l
—
9
49
9
58
1.56
0.70
1.1
1.1
—
—
—
0
0
14
93
1.52
0.70
2.4
1.4
—
—
—
0
0
7
44
1.60
0.65
1.1
1.2
9.86
7.27
mm/h
—
7
44
30
234
1.30
0.64
1.5
1.3
3.19
4.28
ug/l
0.72
30
218
12
79
1.53
0.63
1.1
1.2
103.50
94.88
%
0.47
12
74
31
389
0.79
0.61
3.3
2.9
32.33
31.22
%
0.20
24
289
5
30
1.67
0.61
1.0
1.0
—
—
—
0
0
0
22
0.00
0.59
0.0
1.5
—
—
—
0
0
0
22
0.00
0.59
0.0
1.5
—
—
—
0
0
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
32
396
0.80
0.57
1.9
1.8
—
—
—
0
0
121
1094
1.13
0.56
3.7
2.1
—
—
—
0
0
6
37
1.63
0.55
2.8
2.4
21.62
681.27
ug/l
—
6
32
24
186
1.30
0.55
1.8
1.7
—
—
—
0
0
35
426
0.81
0.55
1.6
1.7
—
—
—
0
0
26
204
1.29
0.55
1.8
2.1
3.97
4.13
iu/l
—
8
95
30
240
1.26
0.54
1.5
1.6
0.00
0.09
iu/ml
—
5
42
13
91
1.44
0.53
3.0
1.9
0.98
4.47
ug/l
0.61
13
84
16
117
1.38
0.52
1.6
1.5
—
—
—
0
0
24
188
1.29
0.51
1.6
1.1
—
—
—
0
0
6
40
1.50
0.51
1.0
1.1
147.33
207.59
iu/ml
—
6
40
6
41
1.47
0.50
1.2
1.0
4.50
2.54
u/ml
—
6
41
6
41
1.47
0.50
2.8
1.7
—
—
—
0
0
15
110
1.37
0.49
2.2
1.4
5.22
3.20
u/ml
—
9
56
16
119
1.35
0.48
1.4
1.4
18.04
12.30
u/l
0.34
16
104
15
199
0.75
0.47
1.7
2.1
18.67
33.79
u/ml
1.37
15
190
10
68
1.48
0.47
4.5
1.8
—
—
—
0
0
7
48
1.46
0.47
1.1
1.0
—
—
—
0
0
11
77
1.44
0.45
1.2
1.1
—
—
—
0
0
41
349
1.19
0.44
1.2
1.2
7.60
7.49
u/ml
0.01
25
242
17
131
1.31
0.42
2.5
1.4
—
—
—
0
0
0
16
0.00
0.41
0.0
1.3
—
9.19
—
0
16
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
11
79
1.40
0.41
3.5
3.6
18.09
423.90
u/ml
0.56
11
65
8
60
1.34
0.40
3.0
2.4
0.16
0.13
nmol/l
—
8
45
25
206
1.22
0.38
1.2
1.1
—
13.96
—
0
54
18
144
1.26
0.35
1.2
1.1
4.17
2.97
eliau/ml
—
10
65
6
44
1.37
0.34
1.0
1.4
2.25
1.41
nmol/l
—
6
39
37
321
1.16
0.34
1.3
1.3
—
—
—
0
0
6
87
0.69
0.33
3.2
7.1
3.33
6.33
pmol/l
—
6
87
28
238
1.18
0.33
1.2
1.1
8.87
8.11
u/ml
0.07
15
133
65
589
1.11
0.33
1.4
1.5
—
—
—
0
0
39
344
1.14
0.30
1.2
1.2
1.33
1.20
u/ml
0.06
23
206
43
382
1.13
0.30
1.3
1.2
5.23
3.03
u/ml
0.46
31
245
13
102
1.28
0.30
1.2
1.5
5.70
5.43
umol/l
0.07
13
91
14
113
1.24
0.27
2.2
1.3
1.63
6.33
u/ml
—
8
48
8
66
1.21
0.27
1.6
1.3
—
—
—
0
0
19
160
1.19
0.25
3.8
4.3
2.46
6.91
ug/l
1.27
11
118
13
106
1.23
0.23
2.6
1.3
—
—
—
0
0
5
38
1.32
0.23
2.2
1.3
—
—
—
0
0
543
5494
0.94
0.23
4.3
4.0
—
—
—
0
0
5
39
1.28
0.23
1.2
1.2
—
69.20
—
0
5
7
95
0.73
0.22
2.0
1.6
0.40
0.48
e9/l
—
7
95
109
1034
1.06
0.22
1.7
1.6
—
—
—
0
0
0
11
0.00
0.21
0.0
2.8
—
—
—
0
0
0
11
0.00
0.21
0.0
13.7
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
1339.73
—
0
11
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
11
89
1.24
0.21
2.9
3.2
9.40
25.10
mg/l
—
5
61
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
12
99
1.22
0.19
1.1
1.2
106.17
113.03
%
0.64
12
94
29
260
1.12
0.19
1.2
1.1
10.03
6.65
u/ml
0.26
17
156
6
51
1.18
0.19
1.5
1.3
—
—
—
0
0
14
118
1.19
0.19
1.1
1.1
—
—
—
0
0
36
329
1.10
0.18
2.7
2.5
—
—
—
0
0
11
131
0.84
0.17
2.3
2.1
—
—
—
0
0
10
120
0.83
0.16
2.0
2.0
—
—
—
0
0
6
78
0.77
0.15
7.3
5.6
11.83
8.54
%
—
6
78
26
236
1.11
0.15
1.2
1.1
0.39
1.48
u/ml
0.66
13
95
55
518
1.07
0.15
1.4
1.6
58.23
60.75
ug/l
0.20
45
454
7
87
0.80
0.14
1.6
1.6
6.14
7.10
mmol/l
—
7
77
32
346
0.92
0.14
1.3
1.6
59.63
57.07
ug/l
0.14
32
346
37
346
1.07
0.12
1.2
1.2
3.69
2.90
u/ml
0.17
25
223
17
186
0.91
0.09
1.9
1.8
—
—
—
0
0
11
123
0.89
0.08
1.4
1.7
7.95
7.39
mmol/l
0.39
11
118
46
477
0.96
0.06
1.4
1.5
1.12
1.14
ratio
0.07
25
307
166
1684
0.98
0.06
3.2
2.7
0.00
0.01
estimate
0.96
39
492
90
920
0.97
0.06
1.4
1.6
1135.28
970.85
mu/l
0.40
78
809
10
91
1.10
0.04
1.2
1.5
—
—
—
0
0
46
469
0.98
0.02
1.4
1.5
—
—
—
0
0
37
363
1.02
0.01
2.2
2.0
0.55
0.61
ug/l
0.22
20
125
47
477
0.98
0.01
1.4
1.5
0.90
0.94
ratio
0.43
26
307
47
477
0.98
0.01
1.4
1.5
1.28
1.19
ratio
0.29
26
307
10
104
0.96
0.00
1.6
1.6
—
—
—
0
0
44
436
1.01
0.00
1.4
1.3
247.27
247.00
miu/ml
0.00
16
211
26
259
1.00
0.00
1.4
1.3
—
—
—
0
0
5
57
0.88
0.00
1.8
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
4.8
—
0.33
—
0
6
6
61
0.98
-0.00
1.7
1.3
—
—
—
0
0
5
58
0.86
-0.00
1.8
1.3
—
—
—
0
0
6
62
0.97
-0.00
1.7
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
9.4
—
11.27
—
0
7
6
64
0.94
-0.00
1.3
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
6
62
0.97
-0.00
1.7
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
8.00
—
0
5
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
235.50
—
0
6
5
58
0.86
-0.00
1.8
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: F5_READING – Disorders in reading
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).